About this trial
Non-randomized single-arm prospective clinical study.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy female and male subjects between the ages 40-55.
Non-Smoker.
Fitzpatrick skin type I-VI.
Desire to lift facial lax skin, neck and/or submental and/or improve facial wrinkles appearance.
Disqualifiers
Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
Presence of any active systemic or local infections.
Open wounds or lesions within the intended to treat area.
Tattoo or former tattoo at or near treatment area.
Trial design
Single group
Treatments tested in this trial
SofWave
DeviceThe Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues
Treatment groups
Trial outcomes
Primary outcomes
Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation
Rate of the Improvement in the appearance of lower face and upper neck rejuvenation following SofWave treatment based on Global Aesthetic Improvement Scale (-1=worse, 0=no change, 1=improved, 2=marked improvement, 3=very much improved)
Lower face and upper neck rejuvenation
Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation, as assessed by the study physician using Physician Global Aesthetic Improvement Scale (GAIS; (-1=worse, 0=no change, 1=improved, 2=marked improvement, 3=very much improved)) at 12 weeks follow-up visit.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: